| Description | Orticumab (MLDL1278A) is an antibody that specifically targets and inhibits oxidized or malondialdehyde-modified low-density lipoprotein (oxLDL), playing a role in the modulation of autoimmune responses against oxLDL and showing potential in improving atherosclerosis in animal models. Additionally, Orticumab has been researched for its effectiveness in the improvement of psoriasis [1] [2]. |
| molecular weight | N/A |
| CAS | 1314241-10-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |